Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.

Smith MR, Abubakr Y, Mohammad R, Xie T, Hamdan M, al-Katib A.

Cancer Gene Ther. 1995 Sep;2(3):207-12.

PMID:
8528964
[PubMed - indexed for MEDLINE]
2.

Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.

Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.

Clin Cancer Res. 2002 Apr;8(4):1277-83.

PMID:
11948143
[PubMed - indexed for MEDLINE]
Free Article
3.

Antisense oligonucleotides complementary to immunoglobulin sequences of BCL-2/immunoglobulin fusion transcript induce apoptosis of t(14;18) lymphoma cells.

Smith MR, Xie T, Zhou ZZ, Joshi I.

Br J Haematol. 2000 Dec;111(4):1087-92.

PMID:
11167744
[PubMed - indexed for MEDLINE]
4.

Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.

Morelli S, Alama A, Quattrone A, Gong L, Copreni E, Canti G, Nicolin A.

Anticancer Drug Des. 1996 Jan;11(1):1-14.

PMID:
8639245
[PubMed - indexed for MEDLINE]
5.

Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.

Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.

Mol Urol. 2001 Summer;5(2):71-8.

PMID:
11690551
[PubMed - indexed for MEDLINE]
6.

Investigations of antisense oligonucleotides targeted against bcl-2 RNAs.

Kitada S, Miyashita T, Tanaka S, Reed JC.

Antisense Res Dev. 1993 Summer;3(2):157-69.

PMID:
8400801
[PubMed - indexed for MEDLINE]
7.

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.

Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.

J Natl Cancer Inst. 1997 Jul 16;89(14):1027-36.

PMID:
9230884
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.

Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.

Oncogene. 1996 Jul 4;13(1):105-15.

PMID:
8700536
[PubMed - indexed for MEDLINE]
11.

Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.

Cotter FE, Johnson P, Hall P, Pocock C, al Mahdi N, Cowell JK, Morgan G.

Oncogene. 1994 Oct;9(10):3049-55.

PMID:
8084613
[PubMed - indexed for MEDLINE]
12.

Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.

Gillardon F, Zimmermann M, Uhlmann E, Krajewski S, Reed JC, Klimaschewski L.

J Neurosci Res. 1996 Mar 15;43(6):726-34.

PMID:
8984202
[PubMed - indexed for MEDLINE]
13.

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.

J Natl Cancer Inst. 1996 Apr 3;88(7):419-29.

PMID:
8618233
[PubMed - indexed for MEDLINE]
Free Article
14.

Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.

Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.

Clin Cancer Res. 2002 Feb;8(2):607-14.

PMID:
11839683
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.

Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS.

Ann Oncol. 1997;8 Suppl 1:25-30.

PMID:
9187425
[PubMed - indexed for MEDLINE]
16.

Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.

Reed JC, Kitada S, Takayama S, Miyashita T.

Ann Oncol. 1994;5 Suppl 1:61-5.

PMID:
8172820
[PubMed - indexed for MEDLINE]
17.

Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation.

Tormo M, Tari AM, McDonnell TJ, Cabanillas F, Garcia-Conde J, Lopez-Berestein G.

Leuk Lymphoma. 1998 Jul;30(3-4):367-79.

PMID:
9713967
[PubMed - indexed for MEDLINE]
18.

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.

Yamanaka K, Rocchi P, Miyake H, Fazli L, Vessella B, Zangemeister-Wittke U, Gleave ME.

Mol Cancer Ther. 2005 Nov;4(11):1689-98.

PMID:
16275990
[PubMed - indexed for MEDLINE]
Free Article
19.

Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.

Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, Goldie J.

Clin Cancer Res. 1999 Oct;5(10):2891-8.

PMID:
10537358
[PubMed - indexed for MEDLINE]
Free Article
20.

c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.

Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.

Ann Thorac Surg. 1995 Dec;60(6):1583-91.

PMID:
8787447
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk